Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccine Production01:23

Vaccine Production

33
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
33
Vaccines01:21

Vaccines

29
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
29
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

5.2K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
5.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
COP Coated Vesicles00:59

COP Coated Vesicles

18.6K
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of...
18.6K
Vaccinations01:51

Vaccinations

53.5K
Overview
53.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineered thermoswitch in the baculovirus expression vector system for production of virus-like particle vaccines with minimized baculovirus contaminants.

Trends in biotechnology·2025
Same author

Boosting Vaccine Research: The 16-Year Journey of TRANSVAC Vaccine Infrastructure.

Vaccines·2025
Same author

Large-scale production of extracellular vesicles: Report on the "massivEVs" ISEV workshop.

Journal of extracellular biology·2024
Same author

Outer membrane vesicle-based intranasal vaccines.

Current opinion in immunology·2023
Same author

Lipid A heterogeneity and its role in the host interactions with pathogenic and commensal bacteria.

microLife·2023
Same author

Microencapsulated IL-12 Drives Genital Tract Immune Responses to Intranasal Gonococcal Outer Membrane Vesicle Vaccine and Induces Resistance to Vaginal Infection with Diverse Strains of Neisseria gonorrhoeae.

mSphere·2022

Related Experiment Video

Updated: Mar 25, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K

Outer membrane vesicles as platform vaccine technology.

Leo van der Pol1, Michiel Stork2, Peter van der Ley3

  • 1Research, Intravacc, Bilthoven, The Netherlands. leo.van.der.pol@intravacc.nl.

Biotechnology Journal
|February 26, 2016
PubMed
Summary

Outer membrane vesicles (OMVs) are promising vaccine platforms. Genetic engineering enhances OMVs by modifying surface antigens and increasing production, leading to safer and more effective bacterial vaccines.

Keywords:
LipopolysaccharideNeisseriaOuter membrane vesiclePertussisVaccine

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K
Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.7K

Related Experiment Videos

Last Updated: Mar 25, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K
Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.7K

Area of Science:

  • Microbiology
  • Immunology
  • Vaccine Development

Background:

  • Outer membrane vesicles (OMVs) are naturally released by Gram-negative bacteria.
  • OMVs possess inherent immunogenicity and antigen presentation capabilities, making them suitable for vaccine applications.
  • A meningococcal vaccine utilizing OMVs has gained regulatory approval, highlighting their potential.

Purpose of the Study:

  • To explore the potential of genetic engineering in enhancing OMVs for vaccine development.
  • To investigate methods for improving OMV safety, efficacy, and production.
  • To assess the feasibility of developing OMVs as a versatile vaccine platform.

Main Methods:

  • Genetic modification of OMV-producing bacteria to alter antigen expression.
  • Engineering OMVs to reduce reactogenicity (e.g., lipopolysaccharide modification).
  • Optimizing OMV production processes for yield and uniformity.

Main Results:

  • Engineered OMVs can display crucial or multiple antigens, including heterologous ones.
  • Modifications can improve OMV safety and effectiveness, as demonstrated in meningitis B vaccine research.
  • Enhanced production yields and particle characteristics (defined, stable, uniform) are achievable.

Conclusions:

  • Genetic engineering offers a powerful strategy to optimize OMVs as vaccine candidates.
  • OMVs can be tailored to express specific antigens, expanding their application range.
  • Further advancements position OMVs as a versatile platform for developing next-generation vaccines.